Dr. Anna Blakney
-
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
When the next pandemic hits, Canada will be better prepared to respond with homegrown vaccines and therapeutics.
-
Beyond COVID-19: How mRNA technology could transform how we treat disease
Dr. Anna Blakney, assistant professor at UBC’s Michael Smith Laboratories and school of biomedical engineering, describes how mRNA technology could transform how we treat disease.
-
Debunking COVID-19 myths: As the weather warms, UBC vaccine expert separates fact from fiction
Dr. Anna Blakney, assistant professor in UBC’s School of Biomedical Engineering, Michael Smith Laboratories and vaccine expert, addresses some popular myths about COVID-19.